Showing 481-490 of 2254 results for "".
Stroke Spotlight: Subarachnoid Hemorrhage and Cerebral Vasospasm
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-spotlight-subarachnoid-hemorrhage-and-cerebral-vasospasm/31524/Cerebral vasospasm increases morbidity and mortality in persons with subarachnoid hemorrhage.Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy
https://practicalneurology.com/programs/cme/incorporating-fcrn-inhibitors-into-clinical-practice-in-chronic-inflammatory-demyelinating-polyneuropathy/27135/Tune in to learn more about how to incorporate FcRn inhibitors into clinical practice for inflammatory demyelinating polyneuropathy (CIDP).Considerations for the Management of Optic Neuritis in the Inpatient Setting
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/considerations-for-the-management-of-optic-neuritis-in-the-inpatient-setting/31976/Optic neuritis is not only a potential presenting symptom of multiple sclerosis but of other demyelinating and autoimmune diseases.Pompe Disease
https://practicalneurology.com/diseases-diagnoses/child-neurology/pompe-disease/31686/New treatments, available and in development, underscore need for high degree of suspicion for Pompe disease in differential for weakness and respiratory difficulties.Cluster Headache Preventive Therapies
https://practicalneurology.com/diseases-diagnoses/headache-pain/cluster-headache-preventive-therapies/31520/The challenges of cluster headache lead to treatments and further understanding.Trending Autoantibodies Causing Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/trending-autoantibodies-causing-movement-disorders/31709/As new autoantibodies are described, the field of autoimmune movement disorders is ever expanding.Early-Onset Drug-Resistant Epilepsy Due to Gene Variants
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/early-onset-drug-resistant-epilepsy-due-to-gene-variants/31837/Identification of pathogenic gene variants in child-onset drug-resistant epilepsy can be used to guide treatment in children and adults.Stroke Snapshot: Intracerebral Hemorrhage—Surgery and the Future of Clinical Trials
https://practicalneurology.com/columns/stroke/intracerebral-hemorrhage-surgery-and-the-future-of-clinical-trials/35825/By refining patient selection, expanding minimally invasive techniques, and integrating novel therapeutics, the next generation of intracerebral hemorrhage treatment has the potential to shift outcomes from high mortality and disability toward improved survival and functional independence.ICU Care for Severe Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/icu-care-for-severe-traumatic-brain-injury/31988/Special considerations associated with ICU care of severe TBI, including ABC, intracranial hypertension, and neurologic/systemic complicationsMultiple Sclerosis in People Over Age 55
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-people-over-age-55/31759/The average age of people with MS is increasing, but knowledge of the disease in people over age 55 remains sparse.